CRISTIANO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 455
EU - Europa 381
AS - Asia 193
AF - Africa 36
OC - Oceania 2
SA - Sud America 2
Totale 1.069
Nazione #
US - Stati Uniti d'America 451
IT - Italia 193
SG - Singapore 107
SE - Svezia 53
CN - Cina 37
DE - Germania 34
IE - Irlanda 23
IN - India 22
GB - Regno Unito 18
TG - Togo 17
BG - Bulgaria 11
JO - Giordania 11
NL - Olanda 11
FI - Finlandia 10
CI - Costa d'Avorio 9
NG - Nigeria 9
ID - Indonesia 8
CA - Canada 4
IR - Iran 4
LT - Lituania 4
RU - Federazione Russa 4
AT - Austria 3
ES - Italia 3
MK - Macedonia 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
HR - Croazia 2
RS - Serbia 2
CZ - Repubblica Ceca 1
FR - Francia 1
HK - Hong Kong 1
HU - Ungheria 1
JP - Giappone 1
KW - Kuwait 1
LI - Liechtenstein 1
PL - Polonia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 1.069
Città #
Singapore 100
Chandler 66
Bologna 50
Ann Arbor 35
Ashburn 24
Milan 24
Dublin 23
Santa Clara 20
New York 18
Boardman 17
Fairfield 17
Lomé 17
Princeton 14
Amman 11
Florence 11
Redmond 11
Sofia 11
Southend 10
Abeokuta 9
Abidjan 9
Helsinki 9
Jakarta 8
Turin 8
Bremen 7
Rome 6
Wilmington 6
Amsterdam 5
Irvine 5
Los Angeles 4
Osimo 4
Reggio Emilia 4
York 4
Berlin 3
Castel Madama 3
Castellammare del Golfo 3
Catania 3
Dehradun 3
Des Moines 3
Forlì 3
Frankfurt am Main 3
Kolkata 3
Madrid 3
Malvern 3
Modena 3
Nanjing 3
San Diego 3
Vienna 3
Beijing 2
Boydton 2
Busseto 2
Cambridge 2
Castenaso 2
Cervia 2
El Cerrito 2
Guangzhou 2
Hyderabad 2
Mannheim 2
Marburg 2
Miradolo Terme 2
Monza 2
Parma 2
Ravenna 2
Romans d'Isonzo 2
Saint-Laurent 2
San Francisco 2
Santiago 2
Skopje 2
Svilajnac 2
Tianjin 2
Toronto 2
Trecate 2
Washington 2
Woodbridge 2
Wuhan 2
Zhengzhou 2
Acton 1
Andover 1
Bern 1
Bitola 1
Budapest 1
Budrio 1
Canberra 1
Canzo 1
Casalecchio di Reno 1
Chicago 1
Clearwater 1
Coventry 1
Dallas 1
Falkenstein 1
Foshan 1
Fuzhou 1
Henderson 1
Hong Kong 1
Jinhua 1
Jining 1
Kilburn 1
Kuwait City 1
Lappeenranta 1
Leawood 1
Lissone 1
Totale 693
Nome #
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 154
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 144
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 124
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 106
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 73
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 62
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 61
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 58
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 54
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 53
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 52
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 49
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 48
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 34
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study 30
Acute myeloid leukemia mutations: Therapeutic implications 14
Totale 1.116
Categoria #
all - tutte 4.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 3 2 1 0 5
2021/2022213 1 0 6 10 15 8 9 32 16 30 57 29
2022/2023386 37 43 10 35 54 31 10 38 68 8 32 20
2023/2024208 16 19 9 28 15 34 7 18 11 16 29 6
2024/2025298 26 102 46 48 41 35 0 0 0 0 0 0
Totale 1.116